Proposed Development Document for New Source Performance Standards for the Pharmaceutical Manufacturing Point Source Category. (See EPA 440-1-83-084B).
The Environmental Protection Agency (EPA) is proposing regulations that would limit the discharge of five-day biochemical oxygen demand (BOD5) and total suspended solids (TSS) into waters of the United States by new sources in four subcategories of the pharmaceutical manufacturing point source category. This document addresses new source performance standards (NSPS) for conventional pollutants required under the Clean Water Act.
|Office of Water|
|No suboffice specified|
|Effluent Guidelines Division|
|Hund, Frank H.; Smith, Wendy D.|
|Background Cost-Related Document|